LXRX Dividend History & Analysis | N/A Yield
LXRX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 24.5% | 0.31% |
| ABBV | 403,129 M | 3.01% | 9.03% |
| GILD | 150,063 M | 2.62% | 6.53% |
| AMGN | 157,202 M | 3.15% | 4.99% |
| HLN | 41,279 M | 1.90% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 8,004 M | 127% | 60.7% |
| HLN | 41,279 M | 51.0% | 100% |
| AMGN | 157,202 M | 8.90% | 100% |
| ABBV | 403,129 M | 7.06% | 100% |
| GILD | 150,063 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare LXRX Dividends with its Peer-Group
3.01% Yield
3.15% Yield
2.62% Yield
1.90% Yield
LXRX Dividend History: as of November 2025
No dividends paid yet.LXRX Dividend FAQ
Lexicon Pharmaceuticals (NASDAQ:LXRX) is a U.S.-based biopharma focused on discovering, developing, and commercializing small-molecule therapies for cardiovascular, metabolic, and renal diseases. Its lead product, sotagliflozin, is positioned to lower cardiovascular death and heart-failure hospitalizations in patients with heart failure, type-2 diabetes, or chronic kidney disease, while additional candidates in Phase 3 (sotagliflozin for hypertrophic cardiomyopathy and type-1 diabetes), Phase 2 (LX9211 for neuropathic pain), and early development (LX9851 for obesity and cardiometabolic risk) expand its pipeline. The firm leverages strategic collaborations with Viatris and Bristol-Myers Squibb to broaden market reach and share development costs.
What is the Dividend Yield of LXRX?
As of November 2025, LXRX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 1.38.Does LXRX pay a dividend?
As of November 2025 LXRX does not pay a dividend.How often does LXRX pay dividends?
Over the last 12 months, LXRX has issued dividend payments.Will LXRX pay dividends in 2025?
The next Ex-Dividend date for Lexicon Pharmaceuticals (LXRX) is currently unknown.What is the next Ex-Dividend Date for LXRX?
The next Ex-Dividend date for Lexicon Pharmaceuticals (LXRX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of LXRX?
LXRX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of LXRX?
LXRX's 5-Year Yield on Cost is -%. If you bought LXRX's shares at 1.05 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of LXRX?
LXRX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does LXRX have a good Dividend Yield?
LXRX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of LXRX?
The Dividend Payout Ratio of LXRX is unknown.What is the Dividend Rating of LXRX?
LXRX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-20 04:39